World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
26233
World Ranking
14165
National Ranking
1313

Overview

F. Anthony Greco is affiliated with the Sarah Cannon Research Institute in the United Kingdom. Their work primarily focuses on the field of Medicine, with significant contributions across several subfields including Neurology, Surgery, Pathology and Forensic Medicine, Epidemiology, and Oncology.

Their research addresses topics such as:

  • Cancer Diagnosis and Treatment
  • Meningioma and schwannoma management
  • Tumors and Oncological Cases
  • Vestibular and auditory disorders
  • Oral and Maxillofacial Pathology
  • Hearing, Cochlea, Tinnitus, Genetics
  • Head and Neck Surgical Oncology

F. Anthony Greco has published in various well-known venues. Most frequent among these are:

  • Journal of Neurological Surgery Part B Skull Base
  • PubMed
  • European Journal of Cancer
  • Acta Otorrinolaringológica Española
  • Acta Otorrinolaringologica (English Edition)

Some of their recent papers include:

  • "Molecular diagnosis and site-specific therapy in cancer of unknown primary: an important milestone," 2024, The Lancet Oncology
  • "Systematic review of the CUP trials characteristics and perspectives for next-generation studies," 2022, Cancer Treatment Reviews
  • "International consensus on the initial diagnostic workup of cancer of unknown primary," 2022, Critical Reviews in Oncology/Hematology
  • "Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary," 2021, Clinical Cancer Research
  • "The role of site-specific therapy for cancers of unknown primary: A meta-analysis," 2020, European Journal of Cancer

Frequent co-authors in their publications include:

  • Maurizio Iacoangeli
  • Fabrizio Salvinelli
  • Denis Aiudi
  • Alessio Iacoangeli
  • Maurizio Gladi

Best Publications

  • Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide

    S D Williams;S D Williams;R Birch;R Birch;L H Einhorn;L Irwin;L Irwin

  • Diagnostic and therapeutic management of cancer of an unknown primary

    N. Pavlidis;E. Briasoulis;J. Hainsworth;F.A. Greco

  • Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

    F M Muggia;J D Hainsworth;S Jeffers;P Miller

  • Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma

    John D. Hainsworth;Sharlene Litchy;Howard A. Burris;Daniel C. Scullin

  • Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

    John D. Hainsworth;Sharlene Litchy;John H. Barton;Gerry Ann Houston

  • Maximizing Therapeutic Benefit of Rituximab: Maintenance Therapy Versus Re-Treatment at Progression in Patients With Indolent Non-Hodgkin's Lymphoma—A Randomized Phase II Trial of the Minnie Pearl Cancer Research Network

    John D. Hainsworth;Sharlene Litchy;Don W. Shaffer;Van L. Lackey

  • Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.

    L H Einhorn;S D Williams;P J Loehrer;R Birch

  • Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute

    John D. Hainsworth;Mark S. Rubin;David R. Spigel;Ralph V. Boccia

  • Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma

    John D. Hainsworth;Howard A. Burris;Lisa H. Morrissey;Sharlene Litchy

  • Tracheoesophageal Fistula Formation in Patients With Lung Cancer Treated With Chemoradiation and Bevacizumab

    David R. Spigel;John D. Hainsworth;Denise A. Yardley;Eric Raefsky

  • Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    K. Fizazi;F. A. Greco;N. Pavlidis;G. Daugaard

  • Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.

    J D Hainsworth;H A Burris rd;J B Erland;M Thomas

  • Prognostic factors for favorable outcome in disseminated germ cell tumors

    R Birch;S Williams;A Cone;L Einhorn

  • Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.

    C R Nichols;S D Williams;P J Loehrer;F A Greco

  • Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

    Ronald B. Natale;Sumitra Thongprasert;F. Anthony Greco;Michael Thomas

  • Molecular Profiling of Carcinoma of Unknown Primary and Correlation With Clinical Evaluation

    Gauri R. Varadhachary;Dmitri Talantov;Martin N. Raber;Christina Meng

  • Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.

    D H Johnson;F A Greco;J Strupp;K R Hande

  • Treatment of Patients with Cancer of an Unknown Primary Site

    J D Hainsworth;F A Greco

  • Acute Vascular Ischemic Events After Cisplatin-Based Combination Chemotherapy for Germ-Cell Tumors of the Testis

    Donald C. Doll;Alan F. List;F. Anthony Greco;John D. Hainsworth

  • Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report.

    C A Perez;L Einhorn;R K Oldham;F A Greco

Frequent Co-Authors

John D. Hainsworth
John D. Hainsworth Sarah Cannon Research Institute
Howard A. Burris
Howard A. Burris Sarah Cannon Research Institute
David R. Spigel
David R. Spigel Sarah Cannon Research Institute
David H. Johnson
David H. Johnson The University of Texas Southwestern Medical Center
Jeffrey R. Infante
Jeffrey R. Infante Janssen (Belgium)
Lawrence H. Einhorn
Lawrence H. Einhorn Indiana University
Johanna C. Bendell
Johanna C. Bendell Sarah Cannon Research Institute
Carlos A. Perez
Carlos A. Perez The University of Texas Health Science Center at Houston
Ian W. Flinn
Ian W. Flinn Sarah Cannon Research Institute
Patrick J. Loehrer
Patrick J. Loehrer Indiana University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering a medical career in the USA, there are a range of flexible online degrees that can help accelerate your journey or expand your qualifications. Many healthcare roles now require advanced education, and online nursing programs are a popular choice for those seeking both affordability and convenience.

If you’re already a registered nurse, exploring the cheapest rn to bsn online options can be a smart move to broaden your career opportunities and increase your earning potential. For those looking to reach the highest levels in nursing practice, the cheapest dnp online program might be your fastest and most cost-effective route.

Affordability is a key concern, so it’s wise to compare the cheapest rn to bsn program online to find an option that fits your budget. If you have a non-nursing background but are passionate about making a direct impact in healthcare, consider the online direct entry msn programs for non-nursing majors—these programs are designed for career changers seeking a fast track to advanced nursing roles.

By exploring these diverse pathways, you can find the right online program to suit your career goals and educational background.

Best Scientists Citing F. Anthony Greco

Trending Scientists

Recently Published Articles